Past Tuesday Talks — Clinical Trials and The Challenges Surrounding Patient Access & Recruitment

Tuesday, October 24th, 2023

Presented by Seema Kumar, CEO, Cure

Join us for another insightful episode of Tuesday Talks as Cure CEO Seema Kumar and the founders of the Clinical Trial Guide discuss the challenges of recruiting patients into studies of investigational treatments. We will explore how pharmaceutical companies and regulators have increased their focus on diversity and inclusion in studies so trial participants better represent clinically relevant patient populations. Learn how trials are changing to enroll people whose genders, ethnicities, races, ages or disabilities have been traditionally underrepresented.

Register now and tune-live on Tuesday, Oct. 24, 2023 at 12:30 PM EDT.

Tuesday Talks — Clinical Trials and The Challenges Surrounding Patient Access & Recruitment

When: Tuesday, October 24, 12:30 PM EDT
Where: Virtual on LinkedIn Live

Topic: A discussion on the challenges of recruiting patients into studies of investigational treatments, and more.

Speakers: David Polinsky and Rika Szafranksi of Clinical Trials Guide. Moderated by Seema Kumar, CEO of Cure

Featured Speakers

David Polinsky

About David Polinski

David Polinsky is an attorney and seasoned executive with experience in industries such as biotechnology, technology and real estate. He started his career in partnership with the Honorable Edward I. Koch, the former Mayor of NYC where Mr. Polinsky founded and served as CEO of a company that developed in the foundational days of the internet. Mr. Polinsky co-founded Cornerstone Pharmaceuticals where he served as President and General Counsel. Subsequent to that, Mr. Polinsky was part of the team that helped spin Rafael Holdings, Inc. (NYSE: RFL) out of a public company and currently serves as CFO of RFL. Mr. Polinsky co-founded and serves as Chairman of Clinical Trial, LLC the developer of

Rivka Szafranski

About Rivka Szafranski

Rivka Szafranski is a passionate and goal-oriented entrepreneur who has dedicated her life to enhancing the lives of individuals and communities across the world. Born and bred in NYC, Rivka studied at Stern College for Women, where she majored in psychology and minored in business management, graduating with honors. Rivka decided to merge her love for the sciences, her business background, and her sincere desire to help people, and decided to earn a masters in Biotechnology Management and Entrepreneurship from the Katz School at Yeshiva University.

Seema Kumar

About Seema Kumar

Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.